価格表

在庫・価格 : 2025年10月08日 10時33分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human IL-23 p19 Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF1716-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥42,000 1個 追加

在庫・価格 : 2025年10月08日 10時33分 現在

Anti-Human IL-23 p19 Affinity Purified Polyclonal Ab

  • 商品コード:AF1716-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥42,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Cunin P et al. The tachykinins substance P and hemokinin-1 favor the generation of human memory Th17 cells by inducing IL-1?, IL-23, and TNF-like 1A expression by monocytes. J. Immunol. 2011 Apr;186(7):4175-82
Cunin P et al
2011/01/01
Species: Human, Applications: Neutralization PubMed
2 Rodrigues KM et al. Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasis. Br. J. Dermatol. 2011 Jun;164(6):1228-34
Rodrigues KM et al
2011/01/01
Species: Human, Applications: IHC-Fr PubMed
3 Aliahmadi E et al. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur. J. Immunol. 2009 May;39(5):1221-30
Aliahmadi E et al
2009/01/01
Species: Human, Applications: Neutralization PubMed
4 Zielinski CE et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012 Apr;484(7395):514-8
Zielinski CE et al
2012/01/01
Species: Human, Applications: Neutralization PubMed
5 Meyers JA et al. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine 2006 Sep;35(5-6):235-46
Meyers JA et al
2006/01/01
Species: Human, Applications: ELISA Development PubMed
6 Olson BM et al. Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J. Immunol. 2012 Dec;189(12):5590-601
Olson BM et al
2012/01/01
Species: Human, Applications: Neutralization PubMed
7 de Paus RA et al. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants. Mol. Immunol. 2008 Sep;45(15):3889-95
de Paus RA et al
2008/01/01
Species: Human, Applications: Neutralization PubMed
  • No.: 1
  • 文献情報:
    Cunin P et al. The tachykinins substance P and hemokinin-1 favor the generation of human memory Th17 cells by inducing IL-1?, IL-23, and TNF-like 1A expression by monocytes. J. Immunol. 2011 Apr;186(7):4175-82
    Cunin P et al
    2011/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Rodrigues KM et al. Influence of the Notch system in the therapeutic response of American tegumentary leishmaniasis. Br. J. Dermatol. 2011 Jun;164(6):1228-34
    Rodrigues KM et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC-Fr
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Aliahmadi E et al. TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur. J. Immunol. 2009 May;39(5):1221-30
    Aliahmadi E et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Zielinski CE et al. Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. Nature 2012 Apr;484(7395):514-8
    Zielinski CE et al
    2012/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Meyers JA et al. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine 2006 Sep;35(5-6):235-46
    Meyers JA et al
    2006/01/01
  • 備考:
    Species: Human, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Olson BM et al. Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade. J. Immunol. 2012 Dec;189(12):5590-601
    Olson BM et al
    2012/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    de Paus RA et al. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants. Mol. Immunol. 2008 Sep;45(15):3889-95
    de Paus RA et al
    2008/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed